- Home
- EVGOW vs LYEL Comparison
EVGOW vs LYEL Comparison
Compare EVGOW & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGOW
- LYEL
- Stock Information
- Founded
- EVGOW 2010
- LYEL 2018
- Country
- EVGOW United States
- LYEL United States
- Employees
- EVGOW 331
- LYEL N/A
- Industry
- EVGOW Other Specialty Stores
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- EVGOW Consumer Discretionary
- LYEL Health Care
- Exchange
- EVGOW Nasdaq
- LYEL Nasdaq
- Market Cap
- EVGOW N/A
- LYEL 207.7M
- IPO Year
- EVGOW N/A
- LYEL 2021
- Fundamental
- Price
- EVGOW $0.20
- LYEL $9.76
- Analyst Decision
- EVGOW
- LYEL Sell
- Analyst Count
- EVGOW 0
- LYEL 2
- Target Price
- EVGOW N/A
- LYEL $15.00
- AVG Volume (30 Days)
- EVGOW 74.7K
- LYEL 142.5K
- Earning Date
- EVGOW 03-07-2025
- LYEL 08-06-2025
- Dividend Yield
- EVGOW N/A
- LYEL N/A
- EPS Growth
- EVGOW N/A
- LYEL N/A
- EPS
- EVGOW N/A
- LYEL N/A
- Revenue
- EVGOW $239,306,000.00
- LYEL $65,000.00
- Revenue This Year
- EVGOW N/A
- LYEL N/A
- Revenue Next Year
- EVGOW N/A
- LYEL N/A
- P/E Ratio
- EVGOW N/A
- LYEL N/A
- Revenue Growth
- EVGOW 73.08
- LYEL N/A
- 52 Week Low
- EVGOW $0.12
- LYEL $7.65
- 52 Week High
- EVGOW $1.99
- LYEL $38.40
- Technical
- Relative Strength Index (RSI)
- EVGOW 40.70
- LYEL 51.74
- Support Level
- EVGOW $0.19
- LYEL $9.61
- Resistance Level
- EVGOW $0.22
- LYEL $10.41
- Average True Range (ATR)
- EVGOW 0.02
- LYEL 0.59
- MACD
- EVGOW -0.00
- LYEL 0.04
- Stochastic Oscillator
- EVGOW 50.85
- LYEL 64.87
About EVGOW EVgo Inc.
EVgo owns and operates a public direct current fast-charging network in the US. Its network of charging stations provides electric vehicle charging infrastructure to consumers and businesses. The network is capable of charging all EV models and meets all charging standards currently available in the US. EVgo partners with national and regional chains of grocery stores, automotive original equipment manufacturers, hotels, shopping centers, gas stations, parking lot operators, local governments, and independent property owners to locate and deploy its EV charging infrastructure.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.